FDA.reportPublic FDA data

NDC 11789-252-20 - Thyro-Tabs Canine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
11789-252
Requested NDC
11789-252-20
Package NDCs from labels
11789-252-10, 11789-252-20
Manufacturer
LLOYD, Inc. of Iowa
Effective date
2026-10-02
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Thyro-Tabs Canine - LLOYD, Inc. of IowaLLOYD, Inc. of Iowa2026-10-02PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11789-252-10Thyro-Tabs Canine120 in 1 BOTTLE, PLASTICTABLET1207
11789-252-20Thyro-Tabs Canine1000 in 1 BOTTLE, PLASTICTABLET10007

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11789-252THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]72 package rows20231004_38005382-289a-4293-b58e-b1cda8bc2288.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LEVOTHYROXINE SODIUMACTIVE INGREDIENT9J765S329GTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
LEVOTHYROXINEACTIVE MOIETYQ51BO43MG4THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
D&C RED NO. 7INACTIVE INGREDIENTECW0LZ41X8THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOATHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1MTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
POVIDONE K29/32INACTIVE INGREDIENT390RMW2PEQTHYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2THYRO-TABS CANINE (LEVOTHYROXINE SODIUM) TABLET [LLOYD, INC. OF IOWA]3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 14 · 270 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions52a07ade-4098-477d-874e-dd692667041e2026-03-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892251
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions67f46137-afc4-471b-a6c7-9c2aef92da5d2026-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892251
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMPD-Rx Pharmaceuticals, Inc.70a9bb5c-2259-405e-8d89-cc1db8c707432026-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMPD-Rx Pharmaceuticals, Inc.6f4998ac-0714-4f5d-8944-9e6902b9f0a62026-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892246
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions853d9e86-2b5b-4967-8c22-70ad34f034182026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionsb42fe9dd-8383-4839-9eab-393de388da712026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutionsfa7dd488-de7e-4f9e-87db-18391b723aad2026-02-19Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions394b1006-c160-4668-8684-82d1c44812022026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions8e11401b-f5c2-42ac-ba63-2e71b5626b7e2026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions4520fae0-acce-47a0-af9e-f4f16ea6b2682026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892246
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions2ce47caf-6ece-429c-b5d7-c47ba69528002026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892246
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions99df68ea-4de7-4825-a6d7-894c70d01c282026-02-10Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions4f26f9dc-cf49-4b55-a6f7-f2f579893ee42026-02-10Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions2b737395-0238-400b-95ff-890b95c984252026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMASCLEMED USA INC.42a26f8a-dc67-42e4-abb0-d2602afb1b7d2026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892251
rxcui: 892246
rxcui: 892255
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions1ac29774-2b53-4a3f-97fa-16c2880a08682026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutionsb717aff6-f754-458d-be87-d12d87c5da002026-02-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions62de26a8-d6fc-463f-abe6-4656228c31422026-02-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCffc34bc6-5de5-addb-e053-6294a90a25be2026-01-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892251
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMNuCare Pharmaceuticals, Inc.49136b34-1bc1-ec4e-e063-6394a90ac9dd2026-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 9J765S329G

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.